Package Leaflet: Information for the User
Pitavastatina Normon 1 mg Film-Coated Tablets
Pitavastatina Normon 2 mg Film-Coated Tablets
Pitavastatina Normon 4 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
You have been prescribed Pitavastatina Normon because you have an imbalance of fats, and changes in your diet and lifestyle have not been sufficient to correct it. You must continue with a low-cholesterol diet and changes in your lifestyle while taking Pitavastatina Normon.
Do not take Pitavastatina Normon:
If you have any doubts, consult your doctor or pharmacist before starting to take pitavastatina.
Warnings and precautions
Consult your doctor or pharmacist before starting to take pitavastatina:
If any of the above cases apply to you (or you have any doubts), consult your doctor or pharmacist before starting to take pitavastatina. Also inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While you are taking this medication, your doctor will monitor whether you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in your blood, overweight, and high blood pressure.
Children and adolescents
Pitavastatina should not be administered to children under 6 years old.
Before taking pitavastatina, adolescent girls should receive guidance and counseling on contraceptives.
Other medications and Pitavastatina Normon
Inform your doctor or pharmacist if you are using, have used recently, or may need to use other medications, including those purchased without a prescription, or herbal products. Some medications may make other medications less effective.
In particular, inform your doctor or pharmacist if you are taking any of the following medications:
If any of the above cases apply to you (or you have any doubts), consult your doctor or pharmacist before starting to take pitavastatina.
Taking Pitavastatina Normon with food and drinks
You can take pitavastatina with or without food.
Pregnancy, breastfeeding and fertility
Do not take pitavastatina if you are pregnant or breastfeeding. If you want to become pregnant, inform your doctor before starting to take pitavastatina.
If you are a woman and may become pregnant, you must use an effective contraceptive method while taking pitavastatina. If you become pregnant while taking pitavastatina, stop taking pitavastatina and see your doctor immediately.
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before taking this medication.
Driving and operating machinery
Pitavastatina is not expected to affect your ability to drive or operate machinery. However, if you feel dizzy or drowsy while taking pitavastatina, do not drive or operate machinery or tools.
Pitavastatina Normon contains lactose
Pitavastatina Normon contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Taking this medication
Swallow the tablet whole with water, with or without food. You can take it at any time of the day. However, try to take the tablet at the same time every day.
How much to take
Use in children
Other things you need to know while taking Pitavastatina Normon
If you take morePitavastatina Normonthan you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20 (indicating the medication and the amount ingested).
If you forget to takePitavastatina Normon
Do not worry, take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose.
This medicine can cause the following side effects:
Stop taking pitavastatin and see your doctor immediately if you notice any of the following serious side effects, as you may need urgent medical treatment:
Other side effects are:
Frequent (affecting fewer than 1 in 10 people)
Less frequent (affecting fewer than 1 in 100 people)
Rare (affecting fewer than 1 in 1,000 people)
Side effects of unknown frequency
See your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Other possible side effects
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears after CAD on the packaging and blister. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature.
Store in the original packaging to protect it from light.
Medications should not be thrown down the drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE point of your pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Pitavastatina Normon
The active ingredient is pitavastatina. Each film-coated tablet contains1mg, 2 mg or 4 mg (as pitavastatina calcium).
The other components (excipients) are:
Tablet core: low-substituted hydroxypropylcellulose, hypromellose (E-464), magnesium aluminometasilicate, calcium carbonate, lactose monohydrate, and magnesium stearate.
Tablet coating: Lactose monohydrate, hypromellose (E-464), titanium dioxide (E-171), macrogol, and talc.
Appearance of the product and content of the packaging:
The film-coated tablets are white or almost white, round, and biconvex, with “P1, P2 or P4” printed on one face and flat on the other face.
Pitavastatina Normon 1mg and 2 mg film-coated tabletsare presented in blister packs of 7, 28, 30, 90, and 100 film-coated tablets.
Pitavastatina Normon 4 mg film-coated tablets are presented in blister packs of 7, 28, or 30 film-coated tablets.
Only some package sizes of each concentration may be commercially available.
Holder of the marketing authorization and responsible manufacturer
Laboratorios NORMON, S.A.
Ronda de Valdecarrizo, 6
28760 – Tres Cantos
Madrid (Spain)
Last review date of this leaflet:March 2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.